These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2049814)

  • 41. Protection against endotoxin shock and impaired glucose homeostasis with ATP.
    Filkins JP; Buchanan BJ
    Circ Shock; 1977; 4(3):253-8. PubMed ID: 336238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms involved in the rapid dissipation of plasma epinephrine response to bacterial endotoxin in conscious rats.
    Qi M; Zhou ZZ; Wurster RD; Jones SB
    Am J Physiol; 1991 Dec; 261(6 Pt 2):R1431-7. PubMed ID: 1750568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Failure of tumor necrosis factor to produce hypotensive shock in the absence of endotoxin.
    Neilson IR; Neilson KA; Yunis EJ; Rowe MI
    Surgery; 1989 Aug; 106(2):439-43. PubMed ID: 2669199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Obstructive jaundice in rats results in exaggerated hepatic production of tumor necrosis factor-alpha and systemic and tissue tumor necrosis factor-alpha levels after endotoxin.
    O'Neil S; Hunt J; Filkins J; Gamelli R
    Surgery; 1997 Aug; 122(2):281-6; discussion 286-7. PubMed ID: 9288133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glucose, lactate, insulin, and somatostatin responses to endotoxin in developing rats.
    Yelich MR; Witek-Janusek L
    Shock; 1994 Dec; 2(6):438-44. PubMed ID: 7743375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucose kinetics and body temperature after lethal and nonlethal doses of endotoxin.
    Lang CH; Bagby GJ; Spitzer JJ
    Am J Physiol; 1985 Apr; 248(4 Pt 2):R471-8. PubMed ID: 3885759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating tumor necrosis factor-alpha production during the progression of rat endotoxic sepsis.
    Xuan D; Nicolau DP; Nightingale CH; Quintiliani R
    Chemotherapy; 2001; 47(3):194-202. PubMed ID: 11306788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity.
    Fraker DL; Stovroff MC; Merino MJ; Norton JA
    J Exp Med; 1988 Jul; 168(1):95-105. PubMed ID: 3294337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molsidomine increases endotoxic survival and decreases cytokine production.
    Kumins NH; Hunt J; Gamelli RL; Filkins JP
    Shock; 1997 Mar; 7(3):200-5. PubMed ID: 9068086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic and neuropathologic effects of E. coli endotoxin in neonatal dogs.
    Young RS; Yagel SK; Towfighi J
    Pediatr Res; 1983 May; 17(5):349-53. PubMed ID: 6343996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute alcohol infusion suppresses endotoxin-induced serum tumor necrosis factor.
    D'Souza NB; Bagby GJ; Nelson S; Lang CH; Spitzer JJ
    Alcohol Clin Exp Res; 1989 Apr; 13(2):295-8. PubMed ID: 2658671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An assessment of plasma histamine concentrations during documented endotoxic shock.
    Brackett DJ; Hamburger SA; Lerner MR; Jones SB; Schaefer CF; Henry DP; Wilson MF
    Agents Actions; 1990 Nov; 31(3-4):263-74. PubMed ID: 2085142
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microcirculation in intestinal villi: a comparison between hemorrhagic and endotoxin shock.
    Nakajima Y; Baudry N; Duranteau J; Vicaut E
    Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1526-30. PubMed ID: 11704607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endotoxin and tumor necrosis factor-alpha-induced interleukin-8 release in humans.
    van Deventer SJ; Hart M; van der Poll T; Hack CE; Aarden LA
    J Infect Dis; 1993 Feb; 167(2):461-54. PubMed ID: 8421182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glucose kinetics and development of endotoxin tolerance during long-term continuous endotoxin infusion.
    Lang CH; Spitzer JA
    Metabolism; 1987 May; 36(5):469-74. PubMed ID: 3574135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular imaging of lung glucose uptake after endotoxin in mice.
    Zhou Z; Kozlowski J; Goodrich AL; Markman N; Chen DL; Schuster DP
    Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L760-8. PubMed ID: 15980036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exacerbation of toxic effects by endotoxin contamination of recombinant human tumor necrosis factor.
    Ozaki Y; Oyama T; Kume S
    Cancer Chemother Pharmacol; 1989; 23(4):231-7. PubMed ID: 2522355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased resistance to epinephrine infusion in endotoxin-tolerant state.
    Fukuda T; Hata N; Okuma H
    Jpn J Physiol; 1969 Apr; 19(2):143-8. PubMed ID: 5306452
    [No Abstract]   [Full Text] [Related]  

  • 59. Endotoxin dose. II. Effects on glucose biokinetics in Yucatan minipigs.
    Chandrasena LG; Fettman MJ; Hand MS; Cleek JL; Phillips RW
    Am J Physiol; 1983 Apr; 244(4):E399-407. PubMed ID: 6837733
    [No Abstract]   [Full Text] [Related]  

  • 60. Insulin response to continuous glucose load in endotoxin shock in the dog.
    Manny J; Rabinovici N; Schiller M
    Surg Gynecol Obstet; 1977 Aug; 145(2):198-202. PubMed ID: 877838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.